Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Allergy
Interventions
DRUG:
anti-IgE
OTHER:
intranasal allergen
OTHER:
intranasal saline
Sponsor
Medical University of Vienna